The PE Ratio as of December 2025 (TTM) for Glenmark Pharmaceuticals Limited (GLENMARK.BO) is 55.65

According to Glenmark Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 55.65. This represents a change of -91.72% compared to the average of 672.05 of the last 4 quarters.

Glenmark Pharmaceuticals Limited (GLENMARK.BO) Historical PE Ratio (quarterly & annually)

How has GLENMARK.BO PE Ratio performed in the past?

The mean historical PE Ratio of Glenmark Pharmaceuticals Limited over the last ten years is 19.78. The current 55.65 PE Ratio has changed 28.04% with respect to the historical average. Over the past ten years (40 quarters), GLENMARK.BO's PE Ratio was at its highest in in the March 2025 quarter at 2.36K. The PE Ratio was at its lowest in in the September 2023 quarter at -73.65.

Glenmark Pharmaceuticals Limited (GLENMARK.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Glenmark Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Glenmark Pharmaceuticals Limited (GLENMARK.BO) Average PE Ratio

How has GLENMARK.BO PE Ratio performed in the past?

The current PE Ratio of Glenmark Pharmaceuticals Limited (GLENMARK.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Glenmark Pharmaceuticals Limited (GLENMARK.BO) PE Ratio vs. Peers

How is GLENMARK.BO’s PE Ratio compared to its peers?

Glenmark Pharmaceuticals Limited’s PE Ratio is less than Laurus Labs Limited (82.49), less than Laurus Labs Limited (82.49), greater than Aurobindo Pharma Limited (20.79), greater than Alkem Laboratories Limited (28.13), greater than Alkem Laboratories Limited (28.13), greater than Aurobindo Pharma Limited (20.79), greater than GlaxoSmithKline Pharmaceuticals Limited (44.85), greater than GlaxoSmithKline Pharmaceuticals Limited (44.85), less than Biocon Limited (105.10), less than Biocon Limited (105.10),

Build a custom stock screener for Glenmark Pharmaceuticals Limited (GLENMARK.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glenmark Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Glenmark Pharmaceuticals Limited (GLENMARK.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Glenmark Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.